NAV
$46.82
AUM
$3.4B
Expense Ratio
-
Dividend Yield
1.95%
Beta
0.71
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +7.23% | +1.68% | +1.59% | +19.63% | +18.06% | +11.67% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | HSBA.L | HSBC Holdings PLC | 10.32% |
| 2 | AZN.L | AstraZeneca PLC | 8.99% |
| 3 | SHEL.L | Shell PLC | 7.55% |
| 4 | RR.L | Rolls-Royce Holdings PLC | 4.84% |
| 5 | BATS.L | British American Tobacco PLC | 3.97% |
| 6 | ULVR.L | Unilever PLC | 3.96% |
| 7 | RIO.L | Rio Tinto PLC Ordinary Shares | 3.66% |
| 8 | BP.L | BP PLC | 3.53% |
| 9 | GSK.L | GSK PLC | 3.29% |
| 10 | BARC.L | Barclays PLC | 2.70% |
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index is designed to measure the performance of the large- and mid-capitalization segments of the UK market. The fund is non-diversified.
Inception Date: 1996-03-12